Alison J Montpetit1, Areej A Alhareeri, Marty Montpetit, Angela R Starkweather, Lynne W Elmore, Kristin Filler, Lathika Mohanraj, Candace W Burton, Victoria S Menzies, Debra E Lyon, Colleen K Jackson-Cook. 1. Alison J. Montpetit, PhD, RN, is Assistant Professor, School of Nursing, Virginia Commonwealth University, Richmond. Areej A. Alhareeri, BS, is Graduate Student, School of Medicine, Virginia Commonwealth University, Richmond. Marty Montpetit, PhD, is Assistant Professor; and Angela R. Starkweather, PhD, ACNP-BC, CNRNA, is Associate Professor, School of Nursing, Virginia Commonwealth University, Richmond. Lynne W. Elmore, PhD, is Associate Professor, School of Medicine, Virginia Commonwealth University, Richmond. Kristin Filler, RN, BS, is Doctoral Student Fellow; Lathika Mohanraj, PhD, is Postdoctoral Fellow; Candace W. Burton, PhD, RN, FNE, is Assistant Professor; and Victoria S. Menzies, PhD, RN, PMHCNS-BC, is Assistant Professor, School of Nursing, Virginia Commonwealth University, Richmond. Debra E. Lyon, PhD, RN, FNP-BC, FNAP, FAAN, is Executive Associate Dean, and Thomas M. and Irene B. Kirbo Endowed Chair, College of Nursing, University of Florida, Gainesville. Colleen K. Jackson-Cook, PhD, is Professor, School of Medicine, Virginia Commonwealth University, Richmond.
Abstract
BACKGROUND: The exciting discovery that telomere shortening is associated with many health conditions and that telomere lengths can be altered in response to social and environmental exposures has underscored the need for methods to accurately and consistently quantify telomere length. OBJECTIVES: The purpose of this article is to provide a comprehensive summary that compares and contrasts the current technologies used to assess telomere length. DISCUSSION: Multiple methods have been developed for the study of telomeres. These techniques include quantification of telomere length by terminal restriction fragmentation-which was one of the earliest tools used for length assessment-making it the gold standard in telomere biology. Quantitative polymerase chain reaction provides the advantage of being able to use smaller amounts of DNA, thereby making it amenable to epidemiology studies involving large numbers of people. An alternative method uses fluorescent probes to quantify not only mean telomere lengths but also chromosome-specific telomere lengths; however, the downside of this approach is that it can only be used on mitotically active cells. Additional methods that permit assessment of the length of a subset of chromosome-specific telomeres or the subset of telomeres that demonstrate shortening are also reviewed. CONCLUSION: Given the increased utility for telomere assessments as a biomarker in physiological, psychological, and biobehavioral research, it is important that investigators become familiar with the methodological nuances of the various procedures used for measuring telomere length. This will ensure that they are empowered to select an optimal assessment approach to meet the needs of their study designs. Gaining a better understanding of the benefits and drawbacks of various measurement techniques is important not only in individual studies, but also to further establish the science of telomere associations with biobehavioral phenomena.
BACKGROUND: The exciting discovery that telomere shortening is associated with many health conditions and that telomere lengths can be altered in response to social and environmental exposures has underscored the need for methods to accurately and consistently quantify telomere length. OBJECTIVES: The purpose of this article is to provide a comprehensive summary that compares and contrasts the current technologies used to assess telomere length. DISCUSSION: Multiple methods have been developed for the study of telomeres. These techniques include quantification of telomere length by terminal restriction fragmentation-which was one of the earliest tools used for length assessment-making it the gold standard in telomere biology. Quantitative polymerase chain reaction provides the advantage of being able to use smaller amounts of DNA, thereby making it amenable to epidemiology studies involving large numbers of people. An alternative method uses fluorescent probes to quantify not only mean telomere lengths but also chromosome-specific telomere lengths; however, the downside of this approach is that it can only be used on mitotically active cells. Additional methods that permit assessment of the length of a subset of chromosome-specific telomeres or the subset of telomeres that demonstrate shortening are also reviewed. CONCLUSION: Given the increased utility for telomere assessments as a biomarker in physiological, psychological, and biobehavioral research, it is important that investigators become familiar with the methodological nuances of the various procedures used for measuring telomere length. This will ensure that they are empowered to select an optimal assessment approach to meet the needs of their study designs. Gaining a better understanding of the benefits and drawbacks of various measurement techniques is important not only in individual studies, but also to further establish the science of telomere associations with biobehavioral phenomena.
Authors: L A Panossian; V R Porter; H F Valenzuela; X Zhu; Erin Reback; D Masterman; J L Cummings; R B Effros Journal: Neurobiol Aging Date: 2003 Jan-Feb Impact factor: 4.673
Authors: Bethan Britt-Compton; Jan Rowson; Matthew Locke; Ian Mackenzie; David Kipling; Duncan M Baird Journal: Hum Mol Genet Date: 2006-01-18 Impact factor: 6.150
Authors: Athanase Benetos; Jeffrey P Gardner; Mahmoud Zureik; Carlos Labat; Lu Xiaobin; Chris Adamopoulos; Mohamed Temmar; Kathryn E Bean; Frédérique Thomas; Abraham Aviv Journal: Hypertension Date: 2004-01-19 Impact factor: 10.190
Authors: Daniel Lindqvist; Elissa S Epel; Synthia H Mellon; Brenda W Penninx; Dóra Révész; Josine E Verhoeven; Victor I Reus; Jue Lin; Laura Mahan; Christina M Hough; Rebecca Rosser; F Saverio Bersani; Elizabeth H Blackburn; Owen M Wolkowitz Journal: Neurosci Biobehav Rev Date: 2015-05-18 Impact factor: 8.989
Authors: Anthony Y Y Hsieh; Sara Saberi; Abhinav Ajaykumar; Kyle Hukezalie; Izabella Gadawski; Beheroze Sattha; Hélène C F Côté Journal: J Mol Diagn Date: 2016-03-08 Impact factor: 5.568
Authors: Laurie Grieshober; Jean Wactawski-Wende; Rachael Hageman Blair; Lina Mu; Jingmin Liu; Jing Nie; Cara L Carty; Lauren Hale; Candyce H Kroenke; Andrea Z LaCroix; Alex P Reiner; Heather M Ochs-Balcom Journal: Am J Epidemiol Date: 2019-09-01 Impact factor: 4.897